Oncology division

[anonymous]

I have two words for this company:

MARKET ADJUSTMENTS

If you want to retain people, you need to adjust salaries to reflect the market. Oncology reps make, on average, between $185k-215 base with much higher bonus structure. If you want people to stay make it less tempting to leave.

That’s actually the low end of average…

 

[anonymous]

Alex Scott did the dude.

 

[anonymous]

I hear Merck is about to pull the plug. It isn't paying off for them enough to justify the partnership. Looking for the door!

 

[anonymous]

I hear Merck is about to pull the plug. It isn't paying off for them enough to justify the partnership. Looking for the door!

A lot of us are

 

[anonymous]

A lot of us are

Yes, because you got your asses kicked by a real biotech oncology company...stay down losers!

 

[anonymous]

Yes, because you got your asses kicked by a real biotech oncology company...stay down losers!

Kamikaze!!!

 

[anonymous]

The South is a mess. Tory has made some bad decisions on this one. We are all thinking about whats next but not talking to anyone. This isn't going to end well.

 

[anonymous]

I agree, the south has been a mess for awhile. I have 3rd interview tomorrow and hope I am out of here.

 

[anonymous]

Hopefully you’ll get the stench of eisai off your resume, good luck

 

[anonymous]

How much do Patient Access Liaisons make? What is the bonus?

 

[anonymous]

How much do Patient Access Liaisons make? What is the bonus?

Never heard of that position. Is it a reimbursement positions?

 

[anonymous]

I got to resign today. I didn't realize how under-paid I was. I feels good to be moving on.

 

[anonymous]

Eisai Oncology is good for one thing and one thing only...getting oncology experience so you can leave for a real oncology company in a few years. For that I thank them...past that is it a joke.

 

[anonymous]

My time here is done. Some good people here in the west but most shouldn't be in oncology.

 

[anonymous]

Eisai is the short school bus of the industry.

 

[anonymous]

Think about it this way...Eisai is large multinational company with two very mediocre oncology products. Small biotech startups have more and do more in revenue than Eisai Oncology.

 

[anonymous]

Think about it this way...Eisai is large multinational company with two very mediocre oncology products. Small biotech startups have more and do more in revenue than Eisai Oncology.

Eisai gets a significant portion of its revenue from vitamin supplements (Chocolate BB) and generics in Japan/Asia. The company’s really not capable of much more than that.

 

[anonymous]

Think about it this way...Eisai is large multinational company with two very mediocre oncology products. Small biotech startups have more and do more in revenue than Eisai Oncology.

Spot on! Big Pharma culture with two drugs. Can't wait to get to an oncology biotech and be rid of this nonsense.

 

[anonymous]

Spot on! Big Pharma culture with two drugs. Can't wait to get to an oncology biotech and be rid of this nonsense.

Lol! Who would ever hire your lame ass?

 

[anonymous]

Lol! Who would ever hire your lame ass?

your mother loves this velvet cheddar ass